Literature DB >> 8195803

Synthesis and secretion of transcobalamin II by cultured astrocytes derived from human brain tissue.

J A Begley1, P D Colligan, R C Chu.   

Abstract

Astrocytes derived from human brain tissue secreted a single cobalamin (vitamin B12, Cbl) binding protein over a 4 day period in culture. Cycloheximide reversibly inhibited the release, and the binding protein was identified as transcobalamin II (TCII) based on molecular size, reaction with anti-human TCII antiserum, precipitation with 2.0 M ammonium sulfate and its ability to bind radioactive cyanocobalamin. It also enhanced the cellular incorporation of the vitamin. Our data show that cultured cells from human brain synthesize and secrete TCII and suggests that at least some of the TCII known to be present in cerebrospinal fluid may originate from within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195803     DOI: 10.1016/0022-510x(94)90051-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Hereditary transcobalamin II deficiency: a 22 year follow up.

Authors:  P K Thomas; A V Hoffbrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  Expanding the Spectrum of Methylmalonic Acid-Induced Pallidal Stroke: First Reported Case of Metabolic Globus Pallidus Stroke in Transcobalamin II Deficiency.

Authors:  Lance Harrington Rodan; Navin Mishra; Ivanna Yau; Andrea Andrade; Komudi Siriwardena; Ingrid Tein
Journal:  JIMD Rep       Date:  2013-02-21

Review 3.  Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.

Authors:  Valentin Lacombe; Guy Lenaers; Geoffrey Urbanski
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

4.  Transcellular transport of cobalamin in aortic endothelial cells.

Authors:  Luciana Hannibal; Keerthana Bolisetty; Armend Axhemi; Patricia M DiBello; Edward V Quadros; Sergey Fedosov; Donald W Jacobsen
Journal:  FASEB J       Date:  2018-05-09       Impact factor: 5.191

5.  Assessment of cellular cobalamin metabolism in Gaucher disease.

Authors:  Suelen Porto Basgalupp; Marina Siebert; Charles Ferreira; Sidney Behringer; Ute Spiekerkoetter; Luciana Hannibal; Ida Vanessa Doederlein Schwartz
Journal:  BMC Med Genet       Date:  2020-01-13       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.